Clinical Trial Update: A Study of SGB-7342 in Subjects With Obesity or Overweight [Phase 1]

View source ↗

Summary

A Phase 1 trial of SGB-7342 in obesity/overweight subjects that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SGB-7342

Snippet

Sponsor: Suzhou Sanegene Bio Inc. | Conditions: Obesity & Overweight | Phase 1 | Status: NOT_YET_RECRUITING